Development of a clinically relevant subclassification of luminal breast cancer related to response to endocrine therapy

Endocrine therapy is widely used in clinical practice as adjuvant treatment for luminal breast cancer. Although clinical outcome of patients with this subtype have markedly improved with endocrine therapy, around 30-50% of patients relapse despite treatment. Therefore, as part of the growing concept...

Full description

Bibliographic Details
Main Author: Alfarsi, Lutfi
Format: Thesis (University of Nottingham only)
Language:English
Published: 2020
Subjects:
Online Access:https://eprints.nottingham.ac.uk/61919/

Similar Items